Edition:
India

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

26.32USD
10:16pm IST
Change (% chg)

$0.86 (+3.38%)
Prev Close
$25.46
Open
$25.63
Day's High
$26.58
Day's Low
$25.60
Volume
169,444
Avg. Vol
328,328
52-wk High
$29.20
52-wk Low
$13.13

Select another date:

Wed, Nov 8 2017

BRIEF-Editas Medicine announces Q3 loss per share $0.64

* Editas Medicine announces third quarter 2017 results and update

BRIEF-Editas receives EMA's orphan medicinal product designation for EDIT-101

* Editas Medicine receives EMA's orphan medicinal product designation for EDIT-101 for the treatment of LCA10

BRIEF-Editas Medicine Inc initiates clinical natural history study of Leber Congenital Amaurosis type 10

* Editas Medicine Inc - announced that company initiated a clinical natural history study of Leber Congenital Amaurosis type 10 (LCA10)

BRIEF-Editas Medicine Q2 loss per share $0.65

* Editas Medicine announces second quarter 2017 results and update

BRIEF-Editas Medicine achieves milestone under Juno Therapeutics collaboration

* Editas Medicine achieves milestone under Juno Therapeutics collaboration for technical progress towards overcoming the tumor microenvironment Source text for Eikon: Further company coverage:

BRIEF-Editas Medicine names Andrew Hirsch to board of directors

* Hirsch will also serve as chairman of audit committee of board, hirsch is currently chief financial officer of agios pharmaceuticals Source text for Eikon: Further company coverage:

Select another date: